Fig. 1From: A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancerImmunohistochemistry of the prostatectomy specimen from patient with Lynch syndrome. MLH1, MSH2 and PMS2 immunoreactivity were clearly detected in the malignant epithelium. The tumour was mostly negative for MSH6 staining except for a few scattered cells. White arrows signify MSH6 expression in adjacent smooth muscle cellsBack to article page